On June 13, 2019 IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology company, reported that IMV Chief Executive Officer Frederic Ors will present at the following investor conferences in June (Press release, IMV, JUN 13, 2019, View Source [SID1234537070]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Raymond James Life Sciences and MedTech Conference

Date: Wednesday, June 19, 2019
Time: 4:10 p.m. ET
Format: Presentation and webcast
Location: Lotte New York Palace, New York, NY
The Oppenheimer Summit for Emerging Biotechnology

Date: Wednesday, June 26, 2019 to Friday, June 28, 2019
Format: Attendance and one-on-one presentations
Location: Gurney’s Star Island Resort and Marina, Montauk, NY
A copy of each the investor presentations will be available in the events and presentations section of IMV’s website. Also, a live webcast of IMV’s presentation at the Raymond James Life Sciences and MedTech Conference will be available and archived for 90 days on the events and presentations webpage.